Glibornuride: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
| UNII = VP83E7434R
| UNII = VP83E7434R
| verifiedrevid = 444003955
| verifiedrevid = 444003955
|ImageFile=Glibornuride02.png
|ImageFile=Glibornuride03.png


|ImageSize=200px
|ImageSize=200px
Line 36: Line 36:
   }}
   }}
}}
}}
==Overview==


==Overview==
'''Glibornuride''' ([[International Nonproprietary Name|INN]]) is an [[anti-diabetic drug]] from the group of [[sulfonylurea]]s.<ref>{{cite journal |author=Haupt E, Köberich W, Beyer J, Schöffling K |title=Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects |journal=Diabetologia |volume=7 |issue=6 |pages=449–54 |date=December 1971 |pmid=5004178 |doi=10.1007/bf01212061}}</ref>
'''Glibornuride''' ([[International Nonproprietary Name|INN]]) is an [[anti-diabetic drug]] from the group of [[sulfonylurea]]s.<ref>{{cite journal |author=Haupt E, Köberich W, Beyer J, Schöffling K |title=Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects |journal=Diabetologia |volume=7 |issue=6 |pages=449–54 |date=December 1971 |pmid=5004178 |doi=10.1007/bf01212061}}</ref>



Revision as of 20:57, 6 April 2015

Template:Chembox E number
Glibornuride
Names
IUPAC name
1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
Identifiers
3D model (JSmol)
DrugBank
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG
Properties
C18H26N2O4S
Molar mass 366.48 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Overview

Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]

References

  1. Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.